NextRNA Therapeutics’ Post

Last week, we announced a strategic collaboration with Bayer to develop small molecules targeting long non-coding RNAs (lncRNAs) in oncology. With our Bayer colleagues, we’ll jointly advance two first-in-class, lncRNA-targeted oncology programs in high unmet need indications. Our differentiated approach – which involves inhibiting the function of lncRNAs by disrupting the interaction between lncRNAs and RNA-binding proteins with small molecules – can be leveraged across many therapeutic areas, including oncology and neuroscience, among others. We look forward to working closely with Bayer while continuing to build our internal pipeline and forge strategic partnerships to maximize the broad potential of the lncRNA target class. Read the press release: https://bit.ly/3Xm0q7O #lncRNA #RNA #smallmolecules #darkgenome #oncology #cancer #neuroscience

We’re delighted to announce that NextRNA has entered into a strategic collaboration with Bayer to develop small molecules targeting long non-coding RNAs (lncRNAs) in oncology. lncRNAs represent a vast class of therapeutic targets that recruit RNA-binding proteins (RBPs) to drive pathological processes across diseases. NextRNA’s unique focus on disrupting lncRNA-RBP interactions with small molecules represents an innovative approach to develop a new class of therapeutic agents in oncology, neuroscience, and many other therapeutic areas. With Bayer we’ll jointly advance two first-in-class, lncRNA-targeted oncology programs in high unmet need indications. This marks a transformative milestone for the lncRNA target class and for NextRNA as we work to bring novel small molecule medicines to patients by realizing the potential of lncRNAs! Read the press release: https://bit.ly/3Xm0q7O #lncRNA #RNA #smallmolecules #darkgenome #oncology #cancer

We're #hiring a new Director/Senior Director, Alliance & Program Management in Boston, Massachusetts. Apply today or share this post with your network.

Cheers to these three NextRs on their recent promotions: Nilesh Amatya, Senior Scientist II; Zori Vargas, Associate Scientist; and Lina Freitas, Associate Director of Operations. Congratulations on this next step in your careers, and we look forward to seeing what you accomplish in your new roles!

We are happy to announce that Shana Dobson Mendozza has joined the NextRNA team as our Executive Director of Human Resources. It's great to have you on board, Shana!

We're very excited to share that Hong Liu has joined NextRNA as our VP, Head of Computational Biology. Welcome, Hong, to the NextRNA team!

We look forward to gathering with industry colleagues from around the world at #BIO2024 next week in San Diego! We'll be sharing our continued progress advancing small molecules that inhibit the function of disease-driving lncRNAs with an initial focus on cancer and neurological diseases. See you in San Diego!   Message our CBO & CFO JS Cleiftie for meeting inquiries. #RNA #ncRNA #lncRNA #BIO24 #cancer #oncology #neurologicaldiseases #darkgenome